Could cinnamon really help fight Alzheimer's disease?

Yale School of Medicine researchers have discovered that a clinical trial of epilepsy drug gabapentin (trade name Neurontin) may have actually been a promotional and sales move to increase prescriptions of the medicine.

How do you get to know a disease? Well, first you have to find out who is getting the disease. That is what researchers recently set out to do with regards to arthritis.

Elderly adults who live in institutions like nursing homes are more likely to experience a syndrome known as “sundowning”—and now researchers have clues as to why.

In an interesting twist, researchers discovered about a decade ago that many of the brain patterns seen in epilepsy are also seen in children with autism.

With the creation of MRI imaging, doctors and researchers suddenly had a flood of information available, particularly when it came to neurology. The problem was that it was an overwhelming amount of data.

Genetic counseling is a wonderful tool to learn about your genes and the genes you are passing on to your children. Some fatal genetic disorders, such as Huntington’s disease, which causes some brain cells to waste away, may also be transferred genetically.

Patients with amyotrophic lateral sclerosis (ALS) might lose brain function before any of their friends or loved ones even notice. This could make it difficult for them to make decisions about their own care.

The triggers for some diseases are never discovered. But often times when they are it offers substantial aid toward finding ways to prevent and treat such diseases.